In this study, we propose that PGC‐1α and Pparγ2 may play novel roles in AP by modulating mitochondrial function to suppress inflammation, extending their functional relevance to nonmetabolic diseases. This evidence concerns the gene PPARG and alkaline phosphatase measurement.